Christopher J. Coughlin, Director at Covidien plc (COV), sold 36,000 shares at $62.05 ($2.2M) on 2013-02-05, disclosed to the SEC on 2013-02-06.
Seasonal sale ($2.2M) by Director — this insider has traded COV in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CNC | BUY | 2022-05-03 | $976K | — | Filing → |
| AGN | BUY | 2018-09-07 | $3.5M | — | Filing → |
| ALXN | BUY | 2018-05-02 | $1.2M | — | Filing → |